Cargando…
Comprehensive analyses of PDHA1 that serves as a predictive biomarker for immunotherapy response in cancer
Recent studies have proposed that pyruvate dehydrogenase E1 component subunit alpha (PDHA1), a cuproptosis-key gene, is crucial to the glucose metabolism reprogram of tumor cells. However, the functional roles and regulated mechanisms of PDHA1 in multiple cancers are largely unknown. The Cancer Geno...
Autores principales: | Deng, Langmei, Jiang, Anqi, Zeng, Hanqing, Peng, Xiaoji, Song, Liying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393251/ https://www.ncbi.nlm.nih.gov/pubmed/36003495 http://dx.doi.org/10.3389/fphar.2022.947372 |
Ejemplares similares
-
High expression of six-transmembrane epithelial antigen of prostate 3 promotes the migration and invasion and predicts unfavorable prognosis in glioma
por: Deng, Langmei, et al.
Publicado: (2023) -
Glycogen Metabolism Predicts the Efficacy of Immunotherapy for Urothelial Carcinoma
por: Zhang, Yueming, et al.
Publicado: (2021) -
Data supporting the co-expression of PDHA1 gene and of its paralogue PDHA2 in somatic cells of a family
por: Pinheiro, Ana, et al.
Publicado: (2016) -
Comprehensive analysis for cellular senescence-related immunogenic characteristics and immunotherapy prediction of acute myeloid leukemia
por: Mao, Yan, et al.
Publicado: (2022) -
Upregulation of lncRNA NR_046683 Serves as a Prognostic Biomarker and Potential Drug Target for Multiple Myeloma
por: Dong, Hang, et al.
Publicado: (2019)